NeuroBo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.769; its P/E ratio is -0.13; NeuroBo Pharmaceuticals is scheduled to report earnings on November 15, 2023, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22
Income Statement	-
Total Revenue	-	-	-	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -734.00K	$ -2.60M	$ -2.48M	$ -3.10M	$ -3.22M
EBITDA	$ -734.00K	$ -2.60M	$ -2.48M	$ -3.10M	$ -3.21M
Net Income Common Stockholders	$ -700.00K	$ -2.60M	$ -4.68M	$ -3.11M	$ -3.30M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 28.70M	$ 30.80M	$ 33.40M	$ 6.36M	$ 8.85M
Total Assets	$ 29.19M	$ 31.48M	$ 33.53M	$ 7.56M	$ 10.08M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -28.70M	$ -30.80M	$ -33.40M	$ -6.36M	$ -8.85M
Total Liabilities	$ 3.98M	$ 10.98M	$ 11.78M	$ 1.62M	$ 1.25M
Stockholders Equity	$ 25.23M	$ 20.51M	$ 21.75M	$ 5.94M	$ 8.83M
Cash Flow	-
Free Cash Flow	$ -2.01M	$ -2.55M	$ -1.81M	$ -2.36M	$ -2.72M
Operating Cash Flow	$ -2.01M	$ -2.55M	$ -1.81M	$ -2.36M	$ -2.72M
Investing Cash Flow	-	$ -4.00K	-	$ 0.00	$ 8.00K
Financing Cash Flow	$ -80.00K	-	$ 28.82M	$ -134.00K	$ 0.00

Currency in USD

NeuroBo Pharmaceuticals Earnings and Revenue History

Income Statement >

NeuroBo Pharmaceuticals Debt to Assets

Balance Sheet >

NeuroBo Pharmaceuticals Cash Flow

Cash Flow >

NeuroBo Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing